FindMyRecallSubscribe
Class I: serious health riskTerminated

Pfizer 8.4% Sodium Bicarbonate Injection Recall

8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Sin…

Pfizer Inc. · New York, NY

Risk level
Class I
Reported by FDA
Apr 10, 2019
Recall ID
D-1073-2019
Check your lot numberHow we source this data

Summary

Pfizer recalled 8.4% Sodium Bicarbonate Injection starting Mar 15, 2019. The FDA classified it as Class I (serious health risk) and published enforcement report D-1073-2019 on Apr 10, 2019. Reason: Presence of Particulate Matter; glass particulates. Status: Terminated.

Why it was recalled

Presence of Particulate Matter; glass particulates

Product description

8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02

Lot numbers, UPCs & expiration codes

Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019

Where it was sold

United States and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1073-2019
Classification
Class I
Status
Terminated
Recall initiated
Mar 15, 2019
FDA report date
Apr 10, 2019
Quantity
283,400 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-1073-2019, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
82362
Address
235 E 42nd St
Code information
Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019
Postal code
10017-5703
Report date
Apr 10, 2019
Product type
Drugs
Recall number
D-1073-2019
Classification
Class I
Recalling firm
Pfizer Inc.
Product quantity
283,400 vials
Termination date
Jan 27, 2021
Reason for recall
Presence of Particulate Matter; glass particulates
Voluntary / mandated
Voluntary: Firm initiated
Product description
8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02
Distribution pattern
United States and Puerto Rico
Recall initiation date
Mar 15, 2019
Initial firm notification
Press Release
Center classification date
Mar 29, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1073-2019, published Apr 10, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls